Cargando…
Single blind randomized Phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial
BACKGROUND: The treatment results of external beam radiotherapy for intermediate and high risk prostate cancer patients are insufficient with five-year biochemical relapse rates of approximately 35%. Several randomized trials have shown that dose escalation to the entire prostate improves biochemica...
Autores principales: | Lips, Irene M, van der Heide, Uulke A, Haustermans, Karin, van Lin, Emile NJT, Pos, Floris, Franken, Stefan PG, Kotte, Alexis NTJ, van Gils, Carla H, van Vulpen, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286435/ https://www.ncbi.nlm.nih.gov/pubmed/22141598 http://dx.doi.org/10.1186/1745-6215-12-255 |
Ejemplares similares
-
High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients
por: Lips, Irene M, et al.
Publicado: (2008) -
Longitudinal Correlations Between Intravoxel Incoherent Motion (IVIM) and Dynamic Contrast-Enhanced (DCE) MRI During Radiotherapy in Prostate Cancer Patients
por: Kooreman, Ernst S., et al.
Publicado: (2022) -
Clinical workflow for treating patients with a metallic hip prosthesis using magnetic resonance imaging-guided radiotherapy
por: Keesman, Rick, et al.
Publicado: (2020) -
Improved repeatability of dynamic contrast‐enhanced MRI using the complex MRI signal to derive arterial input functions: a test‐retest study in prostate cancer patients
por: Klawer, Edzo M.E., et al.
Publicado: (2019) -
Specialist versus Primary Care Prostate Cancer Follow-Up: A Process Evaluation of a Randomized Controlled Trial
por: Wollersheim, Barbara M., et al.
Publicado: (2022)